Odyssey Therapeutics Climbs 11% After $304 Million US IPO
Odyssey Therapeutics Inc. shares jumped 11% in its trading debut, after the biopharmaceutical company raised $304 million in an upsized US initial public offering and private placement.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.